| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |